PMID: 1317039Jan 1, 1992

Discriminative stimulus properties of the benzodiazepine receptor antagonist flumazenil

G A Rowan, I. Lucki


Rats were trained to discriminate the stimulus properties of the benzodiazepine (BZ) receptor antagonist flumazenil using a conditioned taste aversion procedure. On drug trials, fluid-restricted rats were injected with flumazenil (32 mg/kg), given access to a 0.25% saccharin solution for 30 min, and injected with LiCl (1.8 mEq/kg IP). On saline trials, injections of saline bracketed the period of saccharin consumption. Acquisition of the discriminated taste aversion, as measured by differential effects on drinking between saline and drug trials, developed after only five pairings of flumazenil with the LiCl injections. Flumazenil did not alter saccharin consumption in unconditioned controls (N = 9) that never received LiCl. The discrimination was also measured by flumazenil's ability to reduce the preference for saccharin over tap water using two-bottle choice tests. Flumazenil demonstrated dose-dependent generalization upon decreasing the training dose as low as 1 mg/kg. Two other BZ receptor antagonists of different chemical structure, CGS 8216 and ZK 93426, substituted completely for the flumazenil stimulus. Partial generalization was exhibited to the partial inverse agonists FG 7142 and beta-CCE, while the full inverse agon...Continue Reading


Sep 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·C Braestrup, R F Squires
Dec 1, 1979·Neuropharmacology·H Barry, E C Krimmer
Feb 1, 1977·The International Journal of the Addictions·C D Copemann
Mar 13, 1990·European Journal of Pharmacology·F Woudenberg, J L Slangen
Jan 1, 1989·Psychopharmacology·F Woudenberg, J L Slangen
Jul 1, 1987·Neuropharmacology·I L Martin
Jan 1, 1985·Psychopharmacology·H S GarchaI P Stolerman
Jan 1, 1986·Psychopharmacology·S E File, S Pellow
Jan 1, 1986·Psychopharmacology·I P StolermanI C Rose
Jan 1, 1985·Psychopharmacology·J De Vry, J L Slangen
Dec 17, 1985·European Journal of Pharmacology·J De Vry, J L Slangen
Jan 2, 1985·European Journal of Pharmacology·N A Ator, R R Griffiths
Jan 1, 1984·Psychopharmacology·L H JensenR Schmiechen
Dec 1, 1983·Neuropharmacology·H Lal, M W Emmett-Oglesby
Apr 9, 1981·Nature·W HunkelerW Haefely
Jan 6, 1983·Nature·L P Prado de CarvalhoJ Rossier
Jun 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·A GuidottiE Costa
Mar 14, 1983·Neuroscience Letters·S E File
Jan 1, 1983·Pharmacology, Biochemistry, and Behavior·T U Järbe, D E McMillan
May 21, 1982·European Journal of Pharmacology·T Haug, K G Götestam
Nov 1, 1991·Behavioural Pharmacology·I. Lucki, J.M. Marcoccia

Related Concepts

CGS 8216
5-isopropoxy-4-methyl-beta-carboline-3-carboxylic acid ethyl ester
Behavior, Animal
Discrimination (Process of Differentiation)
Dose-Response Relationship, Drug

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Pediculosis pubis

Pediculosis pubis is a disease caused by a parasitic insect known as Pthirus pubis, which infests human pubic hair, as well as other areas with hair including eye lashes. Here is the latest research.

Rh Isoimmunization

Rh isoimmunization is a potentially preventable condition that occasionally is associated with significant perinatal morbidity or mortality. Discover the latest research on Rh Isoimmunization here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells. It also follows CRISPR-Cas9 approaches to generating genetic mutants as a means of understanding the effect of genetics on phenotype.

Enzyme Evolution

This feed focuses on molecular models of enzyme evolution and new approaches (such as adaptive laboratory evolution) to metabolic engineering of microorganisms. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Pharmacology of Proteinopathies

This feed focuses on the pharmacology of proteinopathies - diseases in which proteins abnormally aggregate (i.e. Alzheimer’s, Parkinson’s, etc.). Discover the latest research in this field with this feed.

Alignment-free Sequence Analysis Tools

Alignment-free sequence analyses have been applied to problems ranging from whole-genome phylogeny to the classification of protein families, identification of horizontally transferred genes, and detection of recombined sequences. Here is the latest research.